Page 63 - 南京医科大学学报自然科学版
P. 63
第43卷第4期 谢 奇,樊鑫梅,韩永红,等. lnc⁃NEAT1通过miR⁃29c⁃3p/CSPG4信号轴调节黑色素瘤B16细
2023年4月 胞的增殖、迁移和侵袭[J]. 南京医科大学学报(自然科学版),2023,43(04):492⁃501 ·501 ·
[12] AN L F,HUANG J W,HAN X,et al. Downregulation of sion and metastasis of cervical cancer cells by targeting
lncRNA H19 sensitizes melanoma cells to cisplatin by SPARC[J]. Ann Transl Med,2021,9(2):125-137
regulating the miR⁃18b/IGF1 axis[J]. Anticancer Drugs, [17] WANG Y,LIU G,REN L,et al. Long non⁃coding RNA
2020,31(5):473-482 TUG1 recruits miR⁃29c⁃3p from its target gene RGS1 to
[13] DUAN B X,GENG X R,WU Y Q. lncRNA RNCR2 facili⁃
promote proliferation and metastasis of melanoma cells
tates cell proliferation and epithelial⁃mesenchymal transi⁃
[J]. Int J Oncol,2019,54(4):1317-1326
tion in melanoma through HK2⁃mediated Warburg effect
[18] HOFFMANN R M,CRESCIOLI S,MELE S,et al. A novel
via targeting miR⁃495⁃3p[J]. Neoplasma,2021,68(4):
antibody⁃drug conjugate(ADC)delivering a DNA mono⁃
692-701
alkylating payload to chondroitin sulfate proteoglycan
[14] DING F,LAI J D,GAO Y,et al. NEAT1/miR⁃23a⁃3p/
(CSPG4)⁃ expressing melanoma[J]. Cancers(Basel),
KLF3:a novel regulatory axis in melanoma cancer pro⁃
2020,12(4):1029-1050
gression[J]. Cancer Cell Int,2019,19:217-226
[19] KOOPMANS I,HENDRIKS M A J M,VAN GINKEL R J,
[15] HU Z,CAI M,ZHANG Y,et al. MiR⁃29c⁃3p inhibits au⁃
et al. Bispecific antibody approach for improved melanoma⁃
tophagy and cisplatin resistance in ovarian cancer by reg⁃
selective PD⁃L1 immune checkpoint blockade[J]. J Invest
ulating FOXP1/ATG14 pathway[J]. Cell Cycle,2020,19
(2):193-206 Dermatol,2019,139(11):2343-2351
[16] ZOU T,GAO Y,QIE M. MiR⁃29c⁃3p inhibits epithelial⁃ [收稿日期] 2022-09-28
mesenchymal transition to inhibit the proliferation,inva⁃ (责任编辑:蒋 莉)
欢迎关注我刊微博、微信公众号!